Financial Data and Key Metrics Changes - For the full year 2025, the company reported a 3% local currency revenue growth, a 10% local currency Adjusted EBITDA growth, and a 15% local currency Adjusted EPS growth [5][6] - The overall Adjusted EBITDA margin improved by 100 basis points [5] - In Q4 2025, the company achieved a 2% local currency revenue growth and flat adjusted local currency operating profit [5][6] Business Line Data and Key Metrics Changes - The Color Group delivered 7.4% local currency revenue growth and 16.9% local currency operating profit growth for the year, with an Adjusted EBITDA margin improvement to 23.7% from 22.1% [8][10] - The Flavors and Extracts Group experienced a 1.3% local currency revenue decline but a 3.4% increase in local currency operating profit, with an Adjusted EBITDA margin of 16.7% [10][11] - The Asia Pacific Group reported a 2.4% local currency revenue growth and a 3.8% local currency operating profit growth for the year [12][13] Market Data and Key Metrics Changes - The Color Group's performance is driven by strong natural color conversion momentum in the U.S., Canada, and parts of Latin America [6][7] - The Flavors and Extracts Group faced challenges due to severe weather events impacting agricultural ingredients, leading to a one-time inventory loss of approximately $3 million [11][12] - The Asia Pacific Group is expected to recover from regional demand disruptions, with a bounce back anticipated in the latter half of 2026 [13][14] Company Strategy and Development Direction - The company is focused on capturing substantial opportunities in natural color conversions, which is considered the largest opportunity in its history [7][8] - Investments in research and development, production capacity, and supply chain resilience are emphasized to support customer needs during the conversion process [8][16] - The company plans to invest $150 million-$170 million in capital expenditures for 2026, with a total of $225 million to $250 million allocated for natural color conversion-related capital expenditures from 2025 to 2028 [16][17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving double-digit growth in the Color Group for 2026, driven by natural color conversion activities [21][75] - The company anticipates a slower start to 2026 for the Flavors and Extracts Group, with expectations of strengthening revenue and profit performance as the year progresses [12][15] - Management noted that the first half of 2026 will see challenges in profit leverage due to ongoing investments, but expects significant growth in the second half [15][16] Other Important Information - The company reported cash flow from operations of $45 million in Q4 2025, up from $21 million in the same quarter of 2024 [25] - The consolidated adjusted tax rate was 17.1% in Q4 2025, compared to 24.9% in Q4 2024 [24] - The company’s net debt to adjusted EBIT ratio was 2.3x as of December 31, 2025 [25] Q&A Session Summary Question: Conversion opportunity and pipeline for 2026 - Management indicated that approximately $5 million in conversion revenue was invoiced in Q3 and Q4 2025, with expectations for acceleration in Q1 and Q2 2026 [33][34] Question: Impact of FDA changes on conversion timing - Management believes that FDA guidance will not materially change the conversion timelines, as customer commitment to conversion is driven by consumer demand [70][72] Question: Expectations for flavors and extracts improvement - Management expressed confidence in mid-single-digit revenue growth for the Flavors and Extracts Group, with a recovery in agricultural ingredients contributing to this growth [84][86]